1,4,8-Trihydroxy-2-methyl-3-(4-methylvaleryl)-9,10-phenanthrenequinone (24329-93-9)

Identification
Name:	1,4,8-Trihydroxy-2-methyl-3-(4-methylvaleryl)-9,10-phenanthrenequinone
Synonyms:	1,4,8-Trihydroxy-2-methyl-3-(4-methylvaleryl)-9,10-phenanthrenequinone
CAS:	24329-93-9
Molecular Weight:	0
Molecular Structure:
Properties
Safety Data

Other Product

2-(4-METHYLVALERYL)OXAZOLE
9(10H)-Acridinone,1,3,5-trihydroxy-2-(1- hydroxy-3-methyl-3-butenyl)-10-methyl-4- (3-methyl-2-butenyl)-,(-)-
Alanine,N-(2-chloro-4-methylvaleryl)- (6CI)
Valine,N-(2-chloro-4-methylvaleryl)- (6CI)
2-(3-METHYLVALERYL)OXAZOLE
Spiro[cyclopropane-1,2'(1'H)-phenanthrene]-1',- 4'(3'H)-dione,8'-[(formyloxy)methyl]-4'b,5',6',- 7',8',8'a,9',10'-octahydro-3',9',10'-trihydroxy- 2,4'b,8'-trimethyl-,(1S,2R,3'R,4'bS,8'S,8'aR,- 9'S,10'S)-
5,12-Naphthacenedione,8-acetyl-10-[(4-aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy]-9-fluoro-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-
Spiro[benzo[1,2-b:5,4-c']dipyran-2(3H),2'(3'H)-naphtho[2,3-b]furan]-7-carboxylicacid, 4,5',8',9-tetrahydro-4',9',10-trihydroxy-7'-methoxy-5',8',9-trioxo-,methyl ester, (2S)-
9(10H)-Acridinone,1,3,5-trihydroxy-4- methoxy-10-methyl-
9(10H)-Acridinone,1,3,5-trihydroxy-2-(1- hydroxy-3-methyl-3-butenyl)-10-methyl-,(-)-
5,12-Naphthacenedione,8-acetyl-10-[[3-[[(2R)-2-amino-4-methyl-1-oxopentyl]amino]-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-,(8S,10S)-
9(10H)-Acridinone,1,3,5-trihydroxy-10-methyl-2-(3-methyl-2-buten-1-yl)-
9(10H)-Acridinone,1,3,6-trihydroxy-5-methoxy-10-methyl-2-(3-methyl-2-buten-1-yl)-
9(10H)-Anthracenone,10-(3-acetyl-2,6-dihydroxy-4-methoxyphenyl)-1,8,10-trihydroxy-3-methyl-, (-)-
1/C10H17NO/c12-10-7-4-8-11(10)9-5-2-1-3-6-9/h9H,1-8H
5,12-Naphthacenedione, 10-((3-((2-amino-4-methyl-1-oxopentyl)amino)-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, monohydrochloride, (8S-(8-alpha,10-alpha))-
1/C12H9NO/c14-9-11-3-1-2-4-12(11)10-5-7-13-8-6-10/h1-9
Spiro[furan-3(2H),1'(2'H)-phenanthren]-5(4H)- one,2'-[(1R,2S)-2-(acetyloxy)-1-methyl-3- [(2S,4R)-tetrahydro-4-methyl-5-oxo-2- furanyl]propyl]-3',4',4'a,4'b,5',6',7',8',8'a,9',10',- 10'a-dodecahydro-7'-hydroxy-4'b,8',8',10'atetramethyl-,(1'S,2'R,4'aR,4'bR,7'S,8'aR,- 10'aR)-
2-[(8'R,9'S,10'S,13'S,14'S)-13'-methyl-1',2',4',7',8',9',11',12',13',14',15',16'-dodecahydro-10'H-dispiro[1,3-dioxolane-2,17'-cyclopenta[a]phenanthrene-3',2''-[1,3]dioxolan]-10'-yl]ethanamine acetate (1:1)
(1S,2S,3'R,4'bS,7'R,9'S,10'S)-4'b,5',6',7',8',8'aβ,9',10'-Octahydro-3',9',10'-trihydroxy-2,4'b,7'-trimethyl-8'-methylenespiro[cyclopropane-1,2'(1'H)-phenanthrene]-1',4'(3'H)-dione